Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Read More…
Industry, Sector and Symbol
Industry Process control instruments
Sub-IndustryIndustrial Conglomerates
SectorMulti-Sector Conglomerates
Phone202-828-0850
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$19.89 billion
Profitability
Miscellaneous
Employees71,000
Next Earnings Date10/17/2019 (Estimated)
OptionableOptionable
Danaher (NYSE:DHR) Frequently Asked Questions
What is Danaher's stock symbol?
Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."
How often does Danaher pay dividends? What is the dividend yield for Danaher?
Danaher declared a quarterly dividend on Tuesday, May 7th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.17 per share on Friday, July 26th. This represents a $0.68 annualized dividend and a dividend yield of 0.49%. The ex-dividend date of this dividend is Thursday, June 27th. View Danaher's Dividend History.
How were Danaher's earnings last quarter?
Danaher Co. (NYSE:DHR) posted its quarterly earnings data on Thursday, July, 18th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.15 by $0.04. The conglomerate had revenue of $5.16 billion for the quarter, compared to the consensus estimate of $5.09 billion. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The company's quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the business earned $1.15 EPS. View Danaher's Earnings History.
When is Danaher's next earnings date?
What guidance has Danaher issued on next quarter's earnings?
Danaher updated its FY19 earnings guidance on Thursday, July, 18th. The company provided EPS guidance of $4.75-4.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.85.
What price target have analysts set for DHR?
13 equities research analysts have issued 12-month target prices for Danaher's shares. Their predictions range from $110.00 to $174.00. On average, they anticipate Danaher's share price to reach $143.25 in the next year. This suggests a possible upside of 2.5% from the stock's current price. View Analyst Price Targets for Danaher.
What is the consensus analysts' recommendation for Danaher?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 2 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Danaher.
Has Danaher been receiving favorable news coverage?
News coverage about DHR stock has trended positive on Thursday, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Danaher earned a coverage optimism score of 2.5 on InfoTrie's scale. They also gave news stories about the conglomerate a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the immediate future. View News Stories for Danaher.
Are investors shorting Danaher?
Danaher saw a decline in short interest in July. As of July 15th, there was short interest totalling 4,153,300 shares, a decline of 18.4% from the June 15th total of 5,092,200 shares. Based on an average daily trading volume, of 2,350,000 shares, the days-to-cover ratio is currently 1.8 days. Currently, 0.7% of the company's shares are sold short. View Danaher's Current Options Chain.
Who are some of Danaher's key competitors?
Some companies that are related to Danaher include Roper Technologies (ROP), Fortive (FTV), Keysight Technologies (KEYS), Cognex (CGNX), Sensata Technologies (ST), MKS Instruments (MKSI), Mesa Laboratories (MLAB), Rudolph Technologies (RTEC), Hurco Companies (HURC), Crawford United (CRAWA), Hickok (HICKA), Clearsign Combustion (CLIR), International Isotopes (INIS), Sypris Solutions (SYPR) and Electro-Sensors (ELSE).
What other stocks do shareholders of Danaher own?
Who are Danaher's key executives?
Danaher's management team includes the folowing people:
- Mr. Thomas P. Joyce Jr., CEO, Pres & Director (Age 58)
- Mr. Daniel L. Comas, Exec. VP (Age 55)
- Mr. William K. Daniel II, Exec. VP (Age 54)
- Mr. Rainer M. Blair, Exec. VP (Age 55)
- Mr. Joakim Weidemanis, Exec. VP (Age 49)
Who are Danaher's major shareholders?
Danaher's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.73%), Northern Trust Corp (1.24%), Bank of New York Mellon Corp (0.80%), Jennison Associates LLC (0.72%), Parnassus Investments CA (0.66%) and Brown Advisory Inc. (0.65%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Institutional Ownership Trends for Danaher.
Which major investors are selling Danaher stock?
DHR stock was sold by a variety of institutional investors in the last quarter, including Brown Advisory Inc., Findlay Park Partners LLP, Prudential Financial Inc., Caisse DE Depot ET Placement DU Quebec, Quest Capital Management Inc. ADV, Senator Investment Group LP, Cramer Rosenthal Mcglynn LLC and Eaton Vance Management. Company insiders that have sold Danaher company stock in the last year include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Insider Buying and Selling for Danaher.
Which major investors are buying Danaher stock?
DHR stock was bought by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Janus Henderson Group PLC, Janus Henderson Group PLC, Jennison Associates LLC, Railway Pension Investments Ltd, Sustainable Growth Advisers LP, Vanguard Group Inc. and Mirova. View Insider Buying and Selling for Danaher.
How do I buy shares of Danaher?
Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Danaher's stock price today?
One share of DHR stock can currently be purchased for approximately $139.79.
How big of a company is Danaher?
Danaher has a market capitalization of $100.28 billion and generates $19.89 billion in revenue each year. The conglomerate earns $2.65 billion in net income (profit) each year or $4.52 on an earnings per share basis. Danaher employs 71,000 workers across the globe.View Additional Information About Danaher.
What is Danaher's official website?
How can I contact Danaher?
Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]
MarketBeat Community Rating for Danaher (NYSE DHR)
MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote "Outperform" if you believe DHR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DHR will underperform the S&P 500 over the long term. You may vote once every thirty days.
